In an adult woman with early-stage breast cancer undergoing lumpectomy, how does the negative predictive value of indocyanine green (ICG) fluorescence imaging compare to that of frozen-section analysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

ICG Fluorescence vs Frozen Section for Margin Assessment: Negative Predictive Value Comparison

Based on the available evidence, ICG fluorescence imaging demonstrates an excellent negative predictive value of 92.7-100% for detecting residual breast tumor tissue, which is comparable to frozen section analysis's NPV of 99.8%. However, these modalities serve fundamentally different purposes in breast cancer surgery and cannot be directly compared as equivalent alternatives.

Critical Context: Different Clinical Applications

The evidence provided addresses two distinct clinical scenarios that must not be conflated:

ICG Fluorescence Imaging

  • Primary use: Ex vivo assessment of surgical specimens post-neoadjuvant chemotherapy 1
  • NPV reported: 92.7% overall; 100% in patients achieving pathologic complete response 1
  • Mechanism: Detects residual tumor tissue through fluorescence intensity (tumor-to-background ratio)
  • Key limitation: Low specificity (31.7%), resulting in high false-positive rate (68.3%) 1

Frozen Section Analysis

  • Primary use: Intraoperative margin assessment during lumpectomy
  • NPV reported: 99.8% (95.53-99.9% CI) 2
  • Sensitivity/Specificity: 92.5% and 99.8% respectively 2
  • Overall accuracy: 99.63% 2

Key Performance Comparison

When comparing negative predictive values specifically:

  • Frozen section NPV: 99.8% - meaning if frozen section shows negative margins, there is a 99.8% probability margins are truly negative 2
  • ICG fluorescence NPV: 92.7-100% - highly dependent on clinical context (100% in pCR patients, 92.7% overall) 1

Clinical Implications and Limitations

Why These Cannot Be Used Interchangeably:

  1. Frozen section provides histopathologic confirmation with cellular-level detail and is the established standard for intraoperative margin assessment 3

  2. ICG fluorescence shows promise as a screening tool to guide pathologists toward areas requiring detailed examination, but its 68.3% false-positive rate makes it unsuitable as a standalone margin assessment method 1

  3. The 2020 SSO/ASTRO guidelines emphasize obtaining tumor-free margins before radiation therapy, with "no ink on tumor" as the standard for invasive breast cancer 3 - this requires histopathologic confirmation, not fluorescence imaging alone

Important Caveats:

  • ICG's 100% NPV in pCR patients suggests potential utility for excluding residual disease in post-chemotherapy specimens 1
  • The high sensitivity (94.2%) but low specificity (31.7%) means ICG can reliably identify areas that need pathologic examination but generates many false alarms 1
  • Frozen section remains superior for definitive intraoperative decision-making with its 99.8% specificity 2

Practical Algorithm for Clinical Use

For intraoperative margin assessment during lumpectomy:

  • Use frozen section analysis as the gold standard (NPV 99.8%) 2
  • Consider ICG as an adjunct to guide specimen sampling, not as a replacement

For post-NACT specimen evaluation:

  • ICG fluorescence may assist pathologists in identifying areas requiring detailed examination 1
  • Particularly valuable when pCR is suspected (100% NPV in this subset) 1
  • Always confirm with standard histopathology

The evidence does not support replacing frozen section with ICG fluorescence for margin assessment, as they serve complementary rather than equivalent roles in breast cancer surgery.

References

Related Questions

Does indocyanine green (ICG) guided resection improve margin status in breast‑conserving surgery for early‑stage breast cancer?
In an adult female patient with early‑stage breast cancer undergoing breast‑conserving surgery, is the false‑negative margin rate higher with indocyanine green‑guided lumpectomy compared with intra‑operative frozen‑section analysis?
In an adult female patient with early-stage breast cancer undergoing breast-conserving surgery, should a minimum 1 cm margin be maintained from the edge of the indocyanine‑green (ICG) fluorescent specimen?
For a Ureaplasma infection, should the patient take a single 1000 mg dose of azithromycin?
What is esophagogastric junction (EGJ) outflow obstruction with ineffective peristalsis?
What is the appropriate oral magnesium replacement protocol for a patient with a serum magnesium level of 1.0 mg/dL?
In a patient with heart failure, does coronary artery bypass graft (CABG) surgery improve left ventricular function, increase peri‑operative complication rates, prolong survival, and serve as routine secondary prophylaxis (i.e., is it contraindicated)?
Should olive oil be given to a patient who has ingested zinc phosphate?
What is the recommended pediatric dose of albuterol (0.083% solution, 0.5 mg/mL) for acute bronchospasm and for prophylaxis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.